A virus causing cold-like symptoms is making its seasonal rounds, and health officials are urging everyone to take preventive ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus ...

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...

Five years on from the first news of COVID, recent reports of an obscure respiratory virus in China may understandably raise ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

The change was prompted by postmarketing observational studies that suggest an increased risk of GBS within 42 days of ...

COVID-19 has continued to claim lives at an average rate of about 900 deaths per week in the U.S. over the past year.

As cases of the HMPV virus continue to increase in the U.S. and in China, here's what you need to know about the virus.

A study in Ecuador reveals the rapid emergence of SARS-CoV-2 variants, highlighting the importance of strengthening genomic ...

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...

Over 200 million individuals aged 15–49 likely experienced at least one symptomatic outbreak in 2020, highlighting the urgent ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...